The 5α-Reductase Inhibitor Finasteride Reduces Opioid Self-Administration in Animal Models of Opioid Use Disorder

    April 2021 in “ Journal of Clinical Investigation ”
    Gabriel D. Bossé, Roberto Cadeddu, Gabriele Floris, Ryan D. Farero, Eva Vigato, Suhjung Janet Lee, Tejia Zhang, Nilesh W. Gaikwad, Kristen A. Keefe, Paul S Phillips, Marco Bortolato, Randall T. Peterson
    TLDR Finasteride reduces opioid use and withdrawal symptoms in animals.
    The study demonstrated that finasteride, a 5α-reductase inhibitor, significantly reduced opioid self-administration in both zebrafish and rat models. In zebrafish, finasteride reduced hydrocodone self-administration by 73% at concentrations as low as 5 nM, and in rats, it reduced hydrocodone self-administration at doses of 50 mg/kg. The effect was consistent across different opioids, including morphine and fentanyl, and was observed in both male and female rats. Finasteride also alleviated some physical symptoms of opioid withdrawal without affecting the pain-relieving properties of opioids. The study suggested that finasteride's effects might be due to alterations in neuroactive steroid levels in the brain, highlighting its potential as a treatment for opioid use disorder.
    Discuss this study in the Community →

    Research cited in this study

    18 / 18 results

    Related Community Posts Join

    6 / 1000+ results

      community Proof that finasteride messes with neurosteroids

      in Research/Science  230 upvotes 5 months ago
      Finasteride can impact neurosteroids, potentially causing depression and other side effects in some users. Despite these concerns, many continue using it for hair loss, with some switching to topical applications to mitigate side effects.

      community Six months of only Dermarolling

      in Progress Pictures  157 upvotes 1 year ago
      User tried dermarolling for hair loss and shared progress pictures. Some suggest adding finasteride and minoxidil, while others debate effectiveness and frequency of dermarolling.

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  42 upvotes 4 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 3 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community NW5 at 19. How many grafts do I need?

      in Transplants  140 upvotes 1 year ago
      A 19-year-old with rapid hair loss since 16 is considering a hair transplant but refuses to take finasteride or any 5α-Reductase inhibitors. They are currently using minoxidil, tretinoin, and microneedling with a Derminator 2, and only want hair until age 27.

    Related Research

    2 / 2 results